紐文市政收益基金 NMI 深滬

等待開盤 11-04 09:30:00 美东时间

10.03

-0.020

-0.20%

華盛通

立即下載

最高10.05
今開10.05
成交量 1.97万股
最低 9.98
昨收 10.05
總市值 1.01亿
52周最高 10.698
市盈率 ^靜 7.36
換手率 0.20%
52周最低 8.9146
委比 -90.00%
總股本 1006.73万
歷史最高 11.284
量比 0.81
振幅 0.70%
歷史最低 6.796
每手 1
風險率 0.29%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

阿斯利康携四项重磅研究首发数据亮相ESMO，彰显重新定义癌症治疗的雄心

（来源：氨基观察） DESTINY-Breast11与DESTINY-Breast05两项研究入选主席研讨会（Presidential Symposium）...

10-15 12:05
NMI Holdings, Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025

NMI Holdings, Inc. announced it will report third-quarter 2025 results on November 4, 2025, after market close. A conference call and webcast will be held at 2:00 p.m. PT / 5:00 p.m. ET, accessible via (844) 481-2708 or (412) 317-0664, and available on the company's website. A replay and earnings press release will also be provided. The company enables low-down-payment home ownership and protects lenders against defaults.

10-13 20:16
FCP PROVIDES $47.1 MILLION IN CAPITAL FOR 553-UNIT, GROCERY-ANCHORED, LUXURY APARTMENTS IN ARLINGTON, VA

CHEVY CHASE, Md., Oct. 9, 2025 /PRNewswire/ -- FCP® announces it has provided $47.1 million in capital through its Structured Investments platform to finance the construction of a mixed-use ...

10-09 21:16
UroGen Publishes Comprehensive Review Of ZUSDURI For Recurrent LG-IR Non–Muscle-Invasive Bladder Cancer, Titled: "Review of UGN-102: A Reverse Thermal Gel Containing Mitomycin for the Treatment of Recurrent, Low-Grade, Intermediate-Risk Non-Muscle Invasive Bladder Cancer"

UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a comprehensive review of the

10-02 20:05
【上证医药】强生突破性疗法获FDA批准，关注膀胱癌治疗领域未被满足临床需求

（来源：上海证券研究）强生INLEXZO获FDA批准，为首个膀胱内持续释放抗癌药物的给药系统。近日，美国FDA正式批准强生公司创新药物INLEXZO（吉...

09-16 15:25
7点！医械早播报-9/11

（来源：医疗器械创新网） 01 监管政策与招投标（一）监管政策三部门联合建立常态化巡回医疗制度，82 支医疗队赴基层国家卫健委、国家中医药局、国家疾控局联...

09-11 07:00
Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst

Johnson & Johnson analyst Asad Haider says Inlexzo is currently the only intravesical iDRS to deliver cancer meds directly into the bladder.

09-10 22:41
强生(JNJ.US)获FDA批准突破性疗法超80%患者肿瘤完全消失

结果显示，使用Inlexzo治疗的BCG无应答NMIBC患者中有82%达到完全缓解(CR)，即治疗后未观察到癌症迹象(95% CI：72-90)。

09-10 08:52
enGene Holdings Reaches Target Enrollment Of 100 Patients For Pivotal Cohort Of Its Ongoing, Open-Label, Multi-Cohort Phase 2 LEGEND Trial Of Detalimogene Voraplasmid In Patients With High-Risk, NMIBC

Target enrollment of 100 patients with high-risk, BCG-unresponsive NMIBC with CIS achievedenGene plans to provide an update from LEGEND's pivotal cohort in 4Q 2025Biologic License Application (BLA) submission planned for

09-03 19:35
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq...

09-03 04:05

派息除權日	每股總股息	派息日期
2025-10-15	0.04	2025-11-03
2025-09-15	0.04	2025-10-01
2025-08-15	0.04	2025-09-02
2025-07-15	0.04	2025-08-01
2025-06-13	0.04	2025-07-01
2025-05-15	0.04	2025-06-02
2025-04-15	0.04	2025-05-01
2025-03-14	0.04	2025-04-01
2025-02-14	0.04	2025-03-03
2025-01-15	0.04	2025-02-03
2024-12-13	0.04	2024-12-31
2024-11-15	0.04	2024-12-02
2024-10-15	0.04	2024-11-01
2024-09-13	0.04	2024-10-01
2024-08-15	0.04	2024-09-03
2024-07-15	0.04	2024-08-01
2024-06-14	0.04	2024-07-01
2024-05-14	0.04	2024-06-03
2024-04-12	0.04	2024-05-01
2024-03-14	0.04	2024-04-01
2024-02-14	0.03	2024-03-01
2024-01-11	0.03	2024-02-01
2023-12-14	0.03	2023-12-29
2023-11-14	0.03	2023-12-01
2023-10-12	0.03	2023-11-01
2023-09-14	0.03	2023-10-02
2023-08-14	0.03	2023-09-01
2023-07-13	0.03	2023-08-01
2023-06-14	0.03	2023-07-03
2023-05-12	0.03	2023-06-01
2023-04-13	0.03	2023-05-01
2023-03-14	0.03	2023-04-03
2023-02-14	0.03	2023-03-01
2023-01-12	0.03	2023-02-01
2022-12-14	0.03	2022-12-30
2022-11-14	0.03	2022-12-01
2022-10-13	0.03	2022-11-01
2022-09-14	0.03	2022-10-03
2022-08-12	0.03	2022-09-01
2022-07-14	0.03	2022-08-01
2022-06-14	0.03	2022-07-01
2022-05-12	0.03	2022-06-01
2022-04-13	0.03	2022-05-02
2022-03-14	0.03	2022-04-01
2022-02-14	0.03	2022-03-01
2022-01-13	0.03	2022-02-01
2021-12-14	0.03	2021-12-31
2021-11-12	0.03	2021-12-01
2021-10-14	0.03	2021-11-01
2021-09-14	0.03	2021-10-01
2021-08-12	0.03	2021-09-01
2021-07-14	0.03	2021-08-02
2021-06-14	0.03	2021-07-01
2021-05-13	0.03	2021-06-01
2021-04-14	0.03	2021-05-03
2021-03-12	0.03	2021-04-01
2021-02-11	0.03	2021-03-01
2021-01-14	0.03	2021-02-01
2020-12-14	0.03	2020-12-31
2020-11-12	0.03	2020-12-01
2020-10-14	0.03	2020-11-02
2020-09-14	0.03	2020-10-01
2020-08-13	0.03	2020-09-01
2020-07-14	0.03	2020-08-03
2020-06-12	0.03	2020-07-01
2020-05-14	0.03	2020-06-01
2020-04-14	0.03	2020-05-01
2020-03-12	0.03	2020-04-01
2020-02-13	0.04	2020-03-02
2020-01-14	0.04	2020-02-03
2019-12-12	0.07	2019-12-31
2019-11-14	0.04	2019-12-02
2019-10-11	0.04	2019-11-01
2019-09-12	0.04	2019-10-01
2019-08-14	0.04	2019-09-03
2019-07-12	0.04	2019-08-01
2019-06-13	0.04	2019-07-01
2019-05-14	0.04	2019-06-03
2019-04-12	0.04	2019-05-01
2019-03-14	0.04	2019-04-01
2019-02-14	0.04	2019-03-01
2019-01-14	0.04	2019-02-01
2018-12-13	0.11	2018-12-31
2018-11-14	0.04	2018-12-03
2018-10-12	0.04	2018-11-01
2018-09-13	0.04	2018-10-01
2018-08-14	0.04	2018-09-04
2018-07-12	0.04	2018-08-01
2018-06-14	0.04	2018-07-02
2018-05-14	0.04	2018-06-01
2018-04-12	0.04	2018-05-01
2018-03-14	0.04	2018-04-02
2018-02-14	0.39	2018-03-01
2018-01-11	0.04	2018-02-01
2017-12-14	0.04	2017-12-29
2017-11-14	0.04	2017-12-01
2017-10-12	0.04	2017-11-01
2017-09-14	0.04	2017-10-02
2017-08-11	0.04	2017-09-01
2017-07-12	0.04	2017-08-01
2017-06-13	0.04	2017-07-03
2017-05-11	0.04	2017-06-01
2017-04-11	0.04	2017-05-01
2017-03-13	0.04	2017-04-03
2017-02-13	0.04	2017-03-01
2017-01-11	0.04	2017-02-01
2016-12-13	0.04	2016-12-30
2016-11-10	0.04	2016-12-01
2016-10-12	0.04	2016-11-01
2016-09-13	0.04	2016-10-03
2016-08-11	0.04	2016-09-01
2016-07-13	0.04	2016-08-01
2016-06-13	0.04	2016-07-01
2016-05-11	0.04	2016-06-01
2016-04-13	0.04	2016-05-02
2016-03-11	0.04	2016-04-01
2016-02-10	0.04	2016-03-01
2016-01-13	0.04	2016-02-01
2015-12-11	0.05	2015-12-31
2015-11-10	0.04	2015-12-01
2015-10-13	0.04	2015-11-02
2015-09-11	0.04	2015-10-01
2015-08-12	0.04	2015-09-01
2015-07-13	0.04	2015-08-03
2015-06-11	0.04	2015-07-01
2015-05-13	0.04	2015-06-01
2015-04-13	0.04	2015-05-01
2015-03-11	0.04	2015-04-01
2015-02-11	0.04	2015-03-02
2015-01-13	0.04	2015-02-02
2014-12-11	0.05	2014-12-31
2014-11-12	0.04	2014-12-01
2014-10-10	0.04	2014-11-03
2014-09-11	0.04	2014-10-01
2014-08-13	0.05	2014-09-02
2014-07-11	0.05	2014-08-01
2014-06-11	0.05	2014-07-01
2014-05-13	0.05	2014-06-02
2014-04-11	0.05	2014-05-01
2014-03-12	0.05	2014-04-01
2014-02-12	0.05	2014-03-03
2014-01-13	0.05	2014-02-03
2013-12-11	0.05	2013-12-31
2013-11-13	0.05	2013-12-02
2013-10-10	0.05	2013-11-01
2013-09-11	0.05	2013-10-01
2013-08-13	0.05	2013-09-03
2013-07-11	0.05	2013-08-01
2013-06-12	0.05	2013-07-01
2013-05-13	0.05	2013-06-03
2013-04-11	0.05	2013-05-01
2013-03-13	0.05	2013-04-01
2013-02-13	0.05	2013-03-01
2013-01-11	0.05	2013-02-01
2012-12-12	0.05	2012-12-31
2012-11-13	0.05	2012-12-03
2012-10-11	0.05	2012-11-01
2012-09-12	0.05	2012-10-01
2012-08-13	0.05	2012-09-04
2012-07-11	0.05	2012-08-01
2012-06-13	0.05	2012-07-02
2012-05-11	0.05	2012-06-01
2012-04-11	0.05	2012-05-01
2012-03-13	0.05	2012-04-02
2012-02-13	0.05	2012-03-01
2012-01-11	0.05	2012-02-01
2011-12-13	0.05	2011-12-30
2011-11-10	0.05	2011-12-01
2011-10-12	0.05	2011-11-01
2011-09-13	0.05	2011-10-03
2011-08-11	0.05	2011-09-01
2011-07-13	0.05	2011-08-01
2011-06-13	0.05	2011-07-01
2011-05-11	0.05	2011-06-01
2011-04-13	0.05	2011-05-02
2011-03-11	0.05	2011-04-01
2011-02-11	0.05	2011-03-01
2011-01-12	0.05	2011-02-01
2010-12-13	0.05	2010-12-31
2010-11-10	0.05	2010-12-01
2010-10-13	0.05	2010-11-01
2010-09-13	0.05	2010-10-01
2010-08-11	0.05	2010-09-01
2010-07-13	0.05	2010-08-02
2010-06-11	0.05	2010-07-01
2010-05-12	0.05	2010-06-01
2010-04-13	0.05	2010-05-03
2010-03-11	0.05	2010-04-01
2010-02-10	0.05	2010-03-01
2010-01-13	0.05	2010-02-01
2009-12-11	0.05	2009-12-31
2009-11-10	0.05	2009-12-01
2009-10-13	0.05	2009-11-02
2009-09-11	0.05	2009-10-01
2009-08-12	0.04	2009-09-01
2009-07-13	0.04	2009-08-03
2009-06-11	0.04	2009-07-01
2009-05-13	0.04	2009-06-01
2009-04-13	0.04	2009-05-01
2009-03-11	0.04	2009-04-01
2009-02-11	0.04	2009-03-02
2009-01-13	0.04	2009-02-02
2008-12-11	0.04	2008-12-31
2008-11-12	0.04	2008-12-01
2008-10-10	0.04	2008-11-03
2008-09-11	0.04	2008-10-01
2008-08-13	0.04	2008-09-02
2008-07-11	0.04	2008-08-01
2008-06-11	0.04	2008-07-01
2008-05-13	0.04	2008-06-02
2008-04-11	0.04	2008-05-01
2008-03-12	0.04	2008-04-01
2008-02-13	0.04	2008-03-03
2008-01-11	0.04	2008-02-01
2007-12-12	0.04	2007-12-31
2007-11-13	0.04	2007-12-03
2007-10-11	0.04	2007-11-01
2007-09-12	0.04	2007-10-01
2007-08-13	0.04	2007-09-04
2007-07-11	0.04	2007-08-01
2007-06-13	0.04	2007-07-02
2007-05-11	0.04	2007-06-01
2007-04-11	0.04	2007-05-01
2007-03-13	0.04	2007-04-02
2007-02-13	0.04	2007-03-01
2007-01-10	0.04	2007-02-01
2006-12-13	0.05	2006-12-29
2006-11-13	0.04	2006-12-01
2006-10-11	0.04	2006-11-01
2006-09-13	0.04	2006-10-02
2006-08-11	0.04	2006-09-01
2006-07-12	0.04	2006-08-01
2006-06-13	0.04	2006-07-03
2006-05-11	0.04	2006-06-01
2006-04-11	0.04	2006-05-01
2006-03-13	0.04	2006-04-03
2006-02-13	0.04	2006-03-01
2006-01-11	0.04	2006-02-01
2005-12-13	0.04	2005-12-30
2005-11-10	0.04	2005-12-01
2005-10-12	0.04	2005-11-01
2005-09-13	0.04	2005-10-03
2005-08-11	0.04	2005-09-01
2005-07-13	0.04	2005-08-01
2005-06-13	0.04	2005-07-01
2005-05-11	0.04	2005-06-01
2005-04-13	0.04	2005-05-02
2005-03-11	0.04	2005-04-01
2005-02-11	0.04	2005-03-01
2005-01-12	0.04	2005-02-01
2004-12-13	0.04	2004-12-30
2004-11-10	0.04	2004-12-01
2004-10-13	0.04	2004-11-01
2004-09-13	0.04	2004-10-01
2004-08-11	0.04	2004-09-01
2004-07-13	0.04	2004-08-02
2004-06-14	0.04	2004-07-01
2004-05-12	0.04	2004-06-01
2004-04-13	0.04	2004-05-03
2004-03-11	0.04	2004-04-01
2004-02-11	0.05	2004-03-01
2004-01-13	0.05	2004-02-02
2003-12-11	0.05	2003-12-30
2003-11-12	0.05	2003-12-01
2003-10-10	0.05	2003-11-03
2003-09-11	0.05	2003-10-01
2003-08-13	0.05	2003-09-02
2003-07-11	0.05	2003-08-01
2003-06-11	0.05	2003-07-01
2003-05-13	0.05	2003-06-02
2003-04-11	0.05	2003-05-01
2003-03-12	0.05	2003-04-01
2003-02-12	0.05	2003-03-03
2003-01-13	0.05	2003-02-03
2002-12-11	0.05	2002-12-30
2002-11-13	0.05	2002-12-02
2002-10-10	0.05	2002-11-01
2002-09-11	0.05	2002-10-01
2002-08-13	0.05	2002-09-03
2002-07-11	0.05	2002-08-01
2002-06-12	0.05	2002-07-01
2002-05-13	0.05	2002-06-03
2002-04-11	0.05	2002-05-01
2002-03-13	0.05	2002-04-01
2002-02-13	0.05	2002-03-01
2002-01-11	0.05	2002-02-01
2001-12-12	0.05	2001-12-28
2001-11-13	0.06	2001-12-03
2001-10-11	0.06	2001-11-01
2001-09-12	0.06	2001-10-01
2001-08-13	0.06	2001-09-04
2001-07-11	0.06	2001-08-01
2001-06-13	0.06	2001-07-02
2001-05-11	0.06	2001-06-01
2001-04-10	0.06	2001-05-01
2001-03-13	0.06	2001-04-02
2001-02-13	0.06	2001-03-01
2001-01-10	0.06	2001-02-01
2000-12-13	0.06	2000-12-29
2000-11-13	0.06	2000-12-01
2000-10-11	0.06	2000-11-01
2000-09-13	0.06	2000-10-02
2000-08-11	0.06	2000-09-01
2000-07-12	0.06	2000-08-01
2000-06-13	0.06	2000-07-03
2000-05-11	0.06	2000-06-01
2000-04-12	0.06	2000-05-01
2000-03-13	0.06	2000-04-03
2000-02-11	0.06	2000-03-01
2000-01-12	0.06	2000-02-01
1999-12-13	0.12	1999-12-23
1999-11-10	0.06	1999-12-01
1999-10-13	0.06	1999-11-01
1999-09-13	0.06	1999-10-01
1999-08-11	0.06	1999-09-01
1999-07-13	0.06	1999-08-02
1999-06-11	0.06	1999-07-01
1999-05-12	0.06	1999-06-01
1999-04-13	0.06	1999-05-01
1999-03-11	0.06	1999-04-01
1999-02-10	0.06	1999-03-01
1999-01-13	0.06	1999-02-01
1998-12-11	0.06	1998-12-28
1998-11-10	0.06	1998-12-01
1998-10-13	0.06	1998-11-02
1998-09-11	0.06	1998-10-01
1998-08-12	0.06	1998-09-01
1998-07-13	0.06	1998-08-03
1998-06-11	0.06	1998-07-01
1998-05-13	0.06	1998-06-01
1998-04-13	0.06	1998-05-01
1998-03-11	0.06	1998-04-01
1998-02-11	0.06	1998-03-02
1998-01-13	0.06	1998-02-02
1997-12-11	0.09	1997-12-31
1997-11-12	0.06	1997-12-01
1997-10-10	0.06	1997-11-03
1997-09-11	0.06	1997-10-01
1997-08-13	0.06	1997-09-01
1997-07-11	0.06	1997-08-01
1997-06-11	0.06	1997-07-01
1997-05-13	0.06	1997-06-02
1997-04-11	0.06	1997-05-01
1997-03-12	0.06	1997-04-01
1997-02-12	0.06	1997-03-03
1997-01-13	0.06	1997-02-03
1996-12-11	0.05	1996-12-31
1996-11-13	0.06	1996-12-02
1996-10-10	0.06	1996-11-01
1996-09-11	0.06	1996-10-01
1996-08-13	0.06	1996-09-03
1996-07-11	0.06	1996-08-01
1996-06-12	0.06	1996-07-01
1996-05-13	0.06	1996-06-03
1996-04-11	0.06	1996-05-01
1996-03-13	0.06	1996-04-01
1996-02-13	0.06	1996-03-01
1996-01-10	0.06	1996-02-01
1995-12-13	0.06	1995-12-29
1995-11-13	0.06	1995-12-01
1995-10-11	0.06	1995-11-01
1995-09-13	0.06	1995-10-02
1995-08-11	0.06	1995-09-01
1995-07-12	0.06	1995-08-01
1995-06-13	0.06	1995-07-03
1995-05-09	0.07	1995-06-01
1995-04-07	0.07	1995-05-01
1995-03-09	0.07	1995-04-03
1995-02-09	0.07	1995-03-01
1995-01-09	0.07	1995-02-01
1994-12-09	0.07	1994-12-30
1994-11-08	0.07	1994-12-01
1994-10-07	0.07	1994-11-01
1994-09-09	0.07	1994-10-03
1994-08-09	0.07	1994-09-01
1994-07-11	0.07	1994-08-01
1994-06-09	0.07	1994-07-01
1994-05-09	0.07	1994-06-01
1994-04-11	0.07	1994-05-02
1994-03-09	0.07	1994-04-01
1994-02-09	0.07	1994-03-01
1994-01-10	0.07	1994-02-01
1993-12-09	0.07	1993-12-31
1993-11-08	0.07	1993-12-01
1993-10-08	0.07	1993-11-01
1993-09-09	0.07	1993-10-01
1993-08-09	0.07	1993-09-01
1993-07-09	0.07	1993-08-02
1993-06-09	0.07	1993-07-01
1993-05-10	0.07	1993-06-01
1993-04-08	0.07	1993-05-03
1993-03-09	0.07	1993-04-01
1993-02-08	0.07	1993-03-01
1993-01-11	0.07	1993-02-01
1992-12-09	0.07	1992-12-31
1992-11-06	0.07	1992-12-01
1992-10-08	0.07	1992-11-02
1992-09-09	0.07	1992-10-01
1992-08-10	0.07	1992-09-01
1992-07-09	0.07	1992-08-03
1992-06-09	0.07	1992-07-01
1992-05-11	0.07	1992-06-01
1992-04-09	0.07	1992-05-01
1992-03-09	0.07	1992-04-01
1992-02-10	0.07	1992-03-02
1992-01-09	0.07	1992-02-03
1991-12-09	0.05	1991-12-31
1991-11-08	0.07	1991-12-02
1991-10-08	0.07	1991-11-01
1991-09-09	0.07	1991-10-01
1991-08-09	0.07	1991-09-03
1991-07-09	0.07	1991-08-01
1991-06-10	0.07	1991-07-01
1991-05-09	0.07	1991-06-03
1991-04-09	0.07	1991-05-01
1991-03-11	0.07	1991-04-01
1991-02-11	0.07	1991-03-01
1991-01-09	0.07	1991-02-01
1990-12-10	0.07	1990-12-31
1990-11-08	0.07	1990-12-03
1990-10-09	0.07	1990-11-01
1990-09-10	0.07	1990-10-01
1990-08-09	0.07	1990-09-04
1990-07-09	0.07	1990-08-01
1990-06-11	0.07	1990-07-02
1990-05-09	0.07	1990-06-01
1990-04-06	0.07	1990-05-01
1990-03-09	0.07	1990-03-30
1990-02-09	0.07	1990-02-28
1990-01-08	0.07	1990-01-31
1989-12-11	0.07	1989-12-29
1989-11-09	0.07	1989-11-30
1989-10-06	0.07	1989-10-31
1989-09-11	0.07	1989-09-29
1989-08-09	0.07	1989-08-31
1989-07-10	0.07	1989-07-31
1989-06-09	0.07	1989-06-30
1989-05-09	0.07	1989-05-31
1989-04-10	0.07	1989-04-28
1989-03-09	0.07	1989-03-31
1989-02-09	0.07	1989-02-28
1989-01-09	0.07	1989-01-31
1988-12-09	0.07	1988-12-30
1988-11-08	0.07	1988-11-30
1988-10-07	0.07	1988-10-31
1988-09-09	0.06	1988-09-30
1988-08-09	0.05	1988-08-31
1988-07-11	0.05	1988-07-29
1988-06-09	0.05	1988-06-30

公司名稱	Nuveen Municipal Income Fund, Inc.
行業分類	Investment Trusts/Mutual Funds
業務描述	Nuveen Municipal Income Fund is a closed-end investment fund/investment trust. The fund's objective is a high level of current income exempt from federal income tax. The company was founded on April 20, 1988 and is headquartered in Chicago, IL.

紐文市政收益基金 NMI 深 滬

10.03

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

紐文市政收益基金 NMI 深滬